HCV-IN-31
HCV-IN-31 (compound 4) is a HCV inhibitor, with an EC50/EC95 of 15.7 μM for HCV replicon[1].
Product Specifications
CAS Number
[1998705-62-6]
UNSPSC
12352005
Target
HCV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/hcv-in-31.html
Concentration
10mM
Purity
99.69
Solubility
DMSO : 60 mg/mL (ultrasonic)
Smiles
OC[C@@H]1[C@@H](O)[C@](F)(C)[C@H](N2C3=NC(N)=NC(NC)=C3N=C2)O1
Molecular Formula
C12H17FN6O3
Molecular Weight
312.30
References & Citations
[1]Jean-Pierre Sommadossi, et al. BETA-D-2-DEOXY-2-ALPHA-FLUORO-2- BETA-C-SUBSTITUTED-2-MODIFIED N6-SUBSTITUTED PURINE NUCLEOTDES FORHCV TREATMENT. US20160257706A1.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
